Harvard Bioscience (HBIO) Tax Provisions (2010 - 2026)
Harvard Bioscience's (HBIO) quarterly Tax Provisions came in at $117000.0 in Q1 2026, up 123.4% year-on-year from $52372.4 in Q1 2025, and up 130.31% on a QoQ basis from -$386000.0 in Q4 2025.
Harvard Bioscience (HBIO) Tax Provisions (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Tax Provisions data on file, last reported at $117000.0 in Q1 2026.
- On a quarterly basis, Tax Provisions rose 123.4% year-over-year to $117000.0 in Q1 2026; TTM through Mar 2026 was -$142000.0, a 56.04% increase from a year earlier, with the FY2025 full-year figure at -$686000.0, down 259.53% from the prior year.
- Tax Provisions for Q1 2026 stood at $117000.0, up from -$386000.0 in the prior quarter.
- Over the last five years, Tax Provisions for HBIO reached as high as $1.0 million in Q2 2022 and fell as low as -$1.3 million in Q3 2022.
- Historically, Tax Provisions has averaged -$19176.5 across 5 years, with a median of $97000.0 in 2025.
- On a YoY basis, Tax Provisions climbed as much as 11157.14% in 2022 and fell as far as 697.67% in 2022.
- Year by year, Tax Provisions stood at $774000.0 in 2022, then tumbled by 182.3% to -$637000.0 in 2023, then soared by 136.11% to $230000.0 in 2024, then sank by 267.83% to -$386000.0 in 2025, then surged by 130.31% to $117000.0 in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $117000.0 in Q1 2026, -$386000.0 in Q4 2025, and $97000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 231.40 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 76.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 52.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 103.58 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 32.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 29.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 36.12 Mn |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn | 117,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117,000.00 |
| Dec 31, 2025 | -386,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Dec 31, 2024 | 230,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | -353,000.00 |
| Mar 31, 2024 | 210,000.00 |
| Dec 31, 2023 | -637,000.00 |
| Sep 30, 2023 | 677,000.00 |
| Jun 30, 2023 | -1.10 Mn |
| Mar 31, 2023 | 600,000.00 |
| Dec 31, 2022 | 774,000.00 |
| Sep 30, 2022 | -1.29 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | -100,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Sep 30, 2021 | 215,000.00 |
| Jun 30, 2021 | -200,000.00 |